Also known as آسٹیوپوروسس مینجمنٹ
Nephrologist
M.B.B.S (K.E), MRCP (UK), FCPS (Nephrology), ESCE (Nephrology) (UK), CHPE (LGU), Certified Nephrology
Nephrologist
M.B.B.S (K.E), MRCP (UK), FCPS (Nephrology), ESCE (Nephrology) (UK), CHPE (LGU), Certified Nephrology
Internal Medicine Specialist
MBBS, FCPS, MRCP (Ireland), MRCP (Glasgow)
General Physician
MBBS, MCPS (Family Medicine)
General Physician
MBBS, M.Phill (Community Medicine), CHPE, DIP-Diabetology
General Physician
MBBS, M.Phill (Community Medicine), CHPE, DIP-Diabetology
Cardiologist
MBBS, ECFMG, FLEX, Diplomate American Board of Internal Medicine , Diplomate American Board of Cardiovascular Disease, Certification Board of Nuclear Cardiology, FCCP, FACP, FACC
Cardiologist
MBBS, ECFMG, FLEX, Diplomate American Board of Internal Medicine , Diplomate American Board of Cardiovascular Disease, Certification Board of Nuclear Cardiology, FCCP, FACP, FACC
Internal Medicine Specialist
M.B.B.S , M.R.C.P (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Gastroenterologist
MBBS, FCPS, MCPS
Family Physician
MBBS, MCPS (Family Medicine), MRCGP(INT)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures